FIELD: biochemistry.
SUBSTANCE: described protein which binds to genome factor IX (FIX), polynucleotide coding such protein, recovered host cell expressing the protein and method for protein expression. Presented protein includes genetically engineered DNA-binding domain of protein of "zinc finger" type, where DNA-binding domain contains four or five regions of recognising"zinc finger".
EFFECT: presented inventions can be used in clinical practice in patients with hemophilia B.
15 cl, 5 dwg, 1 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS AND COMPOSITIONS FOR THE TREATMENT OF FABRY DISEASE | 2017 |
|
RU2788133C2 |
| MODIFICATION OF B-CELLS | 2018 |
|
RU2783116C2 |
| METHODS AND COMPOSITIONS FOR TREATING HUNTINGTON'S DISEASE | 2015 |
|
RU2691102C2 |
| CELL TARGETING MEDIATED BY CHIMERIC ANTIGEN RECEPTOR | 2018 |
|
RU2783316C2 |
| METHODS AND COMPOSITIONS FOR TREATING FABRY DISEASE | 2020 |
|
RU2822369C2 |
| TAU MODULATORS AND METHODS AND COMPOSITIONS FOR THEIR DELIVERY | 2017 |
|
RU2789459C2 |
| METHODS AND COMPOSITIONS FOR TREATING HUNTINGTON'S DISEASE | 2014 |
|
RU2693891C1 |
| FAD2 PERFORMANCE LOCI AND CORRESPONDING TARGET SITE SPECIFIC BINDING PROTEINS CAPABLE OF INDUCING TARGETED BREAKS | 2013 |
|
RU2656158C2 |
| METHODS AND COMPOSITIONS FOR NUCLEASE-MEDIATED TARGETING OF TRANSGENES | 2013 |
|
RU2650819C2 |
| LIVER-SPECIFIC STRUCTURES, EXPRESSION CASSETTES OF FACTOR VIII AND THEIR APPLICATION METHODS | 2016 |
|
RU2774874C2 |
